🔬 How Many People Have ADHD? What the Data Shows

Compiled by Dr. Ryan Sultan, psychiatrist in NYC and Columbia faculty member.

Contents:
Prevalence Statistics | Demographics & Age | Comorbidity Statistics | Treatment Statistics | Economic & Social Impact | Trends Over Time | International Comparisons | Key Takeaways

ADHD is one of the most common conditions in psychiatry, and the numbers are large enough that the scope surprises most people. As a Columbia University psychiatrist and NIH-funded ADHD researcher, I've compiled the figures below from the CDC, NIMH, and the international meta-analyses, with the source and data year on every number, so the page can be checked rather than trusted.

The numbers tell a consistent story. ADHD is common, it persists into adulthood far more often than was assumed twenty years ago, and among adults it is mostly undiagnosed. It is also one of the more treatable conditions in medicine when it is recognized.

📈 PREVALENCE STATISTICS

Children & Adolescents

Key Insight: The gender difference may reflect diagnostic bias rather than true prevalence. Girls more often present with inattentive-type ADHD without hyperactivity, leading to underdiagnosis. Recent research suggests the actual ratio may be closer to 1:1 when accounting for presentation differences.

Adults

Global Prevalence

Regional Variation: ADHD prevalence varies significantly by region, with higher rates in North America (9-10%) compared to Europe (5-6%) and Asia (3-5%). However, these differences likely reflect diagnostic practices and cultural factors rather than biological differences.

👥 DEMOGRAPHICS & AGE

Age of Diagnosis

Diagnostic Delays: Many individuals aren't diagnosed until adulthood, often after their own child receives an ADHD diagnosis. Women are particularly likely to receive late diagnoses, with average age of diagnosis in the mid-30s. Learn about the ADHD diagnosis process.

Race & Ethnicity Disparities

Source: CDC National Survey of Children's Health

🧩 COMORBIDITY STATISTICS

Most Common Comorbid Conditions

Clinical Significance: The high comorbidity rate means that ADHD treatment must address multiple conditions simultaneously. Untreated comorbidities can significantly impair treatment response. Read comprehensive comorbidity guide.

Rejection Sensitive Dysphoria (RSD)

Emerging Research: While not officially a separate diagnosis, rejection sensitive dysphoria is increasingly recognized as a core feature of ADHD in adults, with nearly universal occurrence. This explains much of the emotional pain experienced by individuals with ADHD.

💊 TREATMENT STATISTICS

Medication Treatment Rates

Treatment Gap: Only 62% of diagnosed children and 25-30% of diagnosed adults receive medication treatment. When you factor in the large number of undiagnosed cases, less than 10% of adults with ADHD are receiving appropriate treatment. Learn about ADHD medication options.

Medication Effectiveness

Combined Treatment Advantage: Medication plus behavioral therapy produces the best outcomes, with response rates exceeding either treatment alone. This multimodal approach is considered the gold standard for ADHD treatment.

💰 ECONOMIC & SOCIAL IMPACT

Economic Burden

Academic Impact

Source: Multiple longitudinal studies following children with ADHD into adulthood

Employment & Workplace Impact

Workplace Challenges: Adults with ADHD experience significantly higher rates of unemployment, underemployment, and job termination. They also report greater difficulty with time management, organization, and completing tasks—core executive function deficits of ADHD.

Relationship & Family Impact

Interpersonal Consequences: ADHD significantly impacts relationships. Adults with ADHD report more conflict, less satisfaction, and higher divorce rates. Children with ADHD have fewer friendships and experience more peer rejection. Treatment improves social functioning dramatically.

📊 TRENDS OVER TIME

Diagnosis Rate Changes

Source: CDC National Survey of Children's Health (multiple years)

Understanding the Trend: ADHD diagnosis rates rose steadily from 2003 to 2011, dipped in the 2016-2019 survey cycle, and reached a new high of 11.4% in the 2022 CDC data. The pandemic years likely contributed: more time at home made attention problems visible to parents, telehealth lowered the barrier to evaluation, and school disruption worsened function in children who had been coping. Most of the long-run rise likely reflects better recognition rather than more ADHD, since community prevalence in population studies has been stable at roughly 5-7% for two decades.

🌍 INTERNATIONAL COMPARISONS

Global Variation Factors: International differences in ADHD rates reflect diagnostic criteria, cultural attitudes toward mental health, healthcare system differences, and access to specialists. True biological prevalence is likely similar across countries.

🎯 KEY TAKEAWAYS

👨‍⚕️ CLINICAL PERSPECTIVE

As a Columbia University psychiatrist who has evaluated and treated thousands of individuals with ADHD, I find these statistics both alarming and hopeful.

Alarming because so many individuals—particularly adults—suffer unnecessarily due to lack of diagnosis and treatment. The 85% undiagnosed rate among adults represents millions of people struggling with impaired functioning, reduced quality of life, and preventable academic and career underachievement.

Hopeful because ADHD is one of the most treatable conditions in psychiatry. With proper diagnosis and evidence-based treatment, individuals with ADHD can thrive. The 70-80% medication response rate exceeds that of most other psychiatric conditions. Combined medication and behavioral therapy approaches produce even better outcomes.

📚 Related ADHD Resources

🩺 Expert ADHD Evaluation in NYC

📖 Data Sources & References

This page cites data from the following peer-reviewed research:

• Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. (2007). "The worldwide prevalence of ADHD: a systematic review and metaregression analysis." American Journal of Psychiatry, 164(6), 942-948. [DOI]
• Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. (2014). "ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis." International Journal of Epidemiology, 43(2), 434-442. [DOI]
• Kessler RC, Adler L, Barkley R, et al. (2006). "The prevalence and correlates of adult ADHD in the United States." American Journal of Psychiatry, 163(4), 716-723. [DOI]
• Danielson ML, Bitsko RH, Holbrook JR, et al. (2018). "Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016." Journal of Clinical Child & Adolescent Psychology, 47(2), 199-212. [DOI]
• Xu G, Strathearn L, Liu B, Yang B, Bao W. (2018). "Twenty-year trends in diagnosed ADHD among US children and adolescents, 1997-2016." JAMA Network Open, 1(4), e181471. [DOI]
• Visser SN, Danielson ML, Bitsko RH, et al. (2014). "Trends in the parent-report of health care provider-diagnosed and medicated ADHD: United States, 2003-2011." Journal of the American Academy of Child & Adolescent Psychiatry, 53(1), 34-46. [DOI]
• Dalsgaard S, Ostergaard SD, Leckman JF, Mortensen PB, Pedersen MG. (2015). "Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder." The Lancet, 385(9983), 2190-2196. [DOI]
• Doshi JA, Hodgkins P, Kahle J, et al. (2012). "Economic impact of childhood and adult ADHD." Journal of the American Academy of Child & Adolescent Psychiatry, 51(10), 990-1002. [DOI]

Statistics are accurate as of March 2026. Data is updated as new research becomes available.

For the complete collection of 108 ADHD research papers, visit our Key ADHD Literature page.